Insight Molecular Diagnostics Inc. Deferred Tax Liabilities, Gross
Insight Molecular Diagnostics Inc. (IMDX) had Deferred Tax Liabilities, Gross of $478.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-26
- 2025-12-31: Deferred Tax Liabilities, Gross $478.00K.
- 2024-12-31: Deferred Tax Liabilities, Gross $4.68M.
- 2023-12-31: Deferred Tax Liabilities, Gross $15.33M.
- 2022-12-31: Deferred Tax Liabilities, Gross $17.39M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $478.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $4.68M 10-K · filed 2026-03-26 |
| 2023-12-31 | $15.33M 10-K · filed 2025-03-24 |
| 2022-12-31 | $17.39M 10-K · filed 2024-04-16 |
| 2021-12-31 | $20.57M 10-K · filed 2023-04-12 |
| 2020-12-31 | $20.57M 10-K · filed 2022-03-11 |
| 2019-12-31 | $3.84M 10-K · filed 2022-03-11 |
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 |
| 2016-12-31 | $761.00K 10-K · filed 2018-04-02 |
| 2015-12-31 | $864.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |